Glycopeptide microarray for autoantibody detection in cancer

Expert Review of Proteomics

Volumn 8, Issue 4, 2011, Pages 435-437

  Reis, Celso A ^a,b   Campos, Diana ^a   Osório, Hugo ^a   Santos, Lúcio Lara ^c  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

Author keywords

autoantibodies; cancer biomarkers; cancer detection; colon; glycopeptides; microarray; rectum

Indexed keywords

AUTOANTIBODY; GLYCAN; GLYCOPEPTIDE; MUCIN 1; MUCIN 4; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; GLYCOSYLATION; HUMAN; IMMUNOREACTIVITY; PROTEIN FUNCTION; PROTEIN MICROARRAY; PROTEIN MODIFICATION;

EID: 80051756126     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/epr.11.30     Document Type: Article

References (9)

1. Hakomori S. Glycosylation defining cancer malignancy: New wine in an old bottle. Proc. Natl Acad. Sci. USA 99, 10231-10233 (2002).
2. Hanash S, Taguchi A. The grand challenge to decipher the cancer proteome. Nat. Rev. Cancer 10, 652-660 (2010).
3. Reis CA, Osorio H, Silva L, Gomes C, David L. Alterations in glycosylation as biomarkers for cancer detection. J. Clin. Pathol. 63(4), 322-329 (2010). Comprehensive review on glycosylation alterations occurring in cancer and clinical applications.
4. Anderson KS, LaBaer J. The sentinel within: Exploiting the immune system for cancer biomarkers. J. Proteome Res. 4(4), 1123-1133 (2005). (Pubitemid 41208670)
5. Wandall HH, Blixt O, Tarp MA et al. Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. Cancer Res. 70, 1306-1313 (2010). Presents the autoantibody signatures to O-glycoepitopes as cancer biomarkers.
6. Pedersen JW, Blixt O, Bennett EP et al. Seromic profiling of colorectal cancer patients with novel glycopeptide microarray. Int. J. Cancer 128(8), 1860-1871 (2011).
7. Blixt O, Cló E, Nudelman AS et al. A high-throughput O-glycopeptide discovery platform for seromic profiling. J. Proteome Res. 9(10), 5250-5261 (2010). Describes in detail the development of the O-glycopeptide microarray platform.
8. Hakomori S. Tumor-associated carbohydrate antigens defining tumor malignancy: Basis for development of anticancer vaccines. Adv. Exp. Med. Biol. 491, 369-402 (2001). (Pubitemid 32595136)
9. Issaq HJ, Waybright TJ, Veenstra TD. Cancer biomarker discovery: Opportunities and pitfalls in analytical methods. Electrophoresis 32(9), 967-975 (2011).